Joonho Shin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joonho Shin has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Atanu Naskar
Mayo Clinic
2 shared publications - Kwang-Sun Kim
Department of Chemistry and Chemistry Institute for Functional Materials, Pusan National University, Busan 46241, Republic of Korea
2 shared publications Anoop Menon
Add‐Vision, Inc., 1600 Green Hills Road, Suite 100, Scotts Valley, CA, USA
1 shared publicationDevin MacKenzie
Add‐Vision, Inc., 1600 Green Hills Road, Suite 100, Scotts Valley, CA, USA
1 shared publication- Dongjoon Ko
Microbiome Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Korea
1 shared publication Eric Jones
Add‐Vision, Inc., 1600 Green Hills Road, Suite 100, Scotts Valley, CA, USA
1 shared publication
Latest Publications
- Open Access
- 17 June 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (12) , 6770
Bioconjugated Thymol-Zinc Oxide Nanocomposite as a Selective and Biocompatible Antibacterial Agent against Staphylococcus Species
Owing to the rapid spread of antibiotic resistance among Staphylococcus species, effective and low-risk alternatives to antibiotics are being actively searched. Thymol (THO), the most abundant component of the oil extracted from thyme, can be considered as a natural antibacterial alternative. However, the low antibacterial activity and non-selectivity of THO limit its usage as a universal anti-Staphylococcus agent. Herein, we report the bioconjugation of THO with ZnO nanoparticle (ZO), which resulted in the TZ nanocomposite (NC), as a potent and selective antibacterial agent against Staphylococcus species, particularly S. epidermidis. The cell-free supernatant (CFS) of ATCC 25923 cultures was employed for the production of TZ NC. Successful production of TZ NC was confirmed via X-ray diffraction (XRD), Fourier-transform infrared (FT-IR) spectroscopy, and ultraviolet–visible (UV–Vis) studies. TZ NC had selective efficacy against Staphylococcus species, with MIC values 2–32-fold lower than THO. The antibacterial mechanisms of TZ NC are proposed to involve membrane rupture, suppression of biofilm formation, and modulation of new cell wall and protein-synthesis-associated cellular pathways. Its biocompatibility against HCT116 cells was also checked. Our findings suggest that the TZ nanocomposite could improve the selectivity and bactericidal activity of THO against target species.
- 17 June 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (12) , 6770
Open AccessBioconjugated Thymol-Zinc Oxide Nanocomposite as a Selective and Biocompatible Antibacterial Agent against Staphylococcus Species
Owing to the rapid spread of antibiotic resistance among Staphylococcus species, effective and low-risk alternatives to antibiotics are being actively searched. Thymol (THO), the most abundant component of the oil extracted from thyme, can be considered as a natural antibacterial alternative. However, the low antibacterial activity and non-selectivity of THO limit its usage as a universal anti-Staphylococcus agent. Herein, we report the bioconjugation of THO with ZnO nanoparticle (ZO), which resulted in the TZ nanocomposite (NC), as a potent and selective antibacterial agent against Staphylococcus species, particularly S. epidermidis. The cell-free supernatant (CFS) of ATCC 25923 cultures was employed for the production of TZ NC. Successful production of TZ NC was confirmed via X-ray diffraction (XRD), Fourier-transform infrared (FT-IR) spectroscopy, and ultraviolet–visible (UV–Vis) studies. TZ NC had selective efficacy against Staphylococcus species, with MIC values 2–32-fold lower than THO. The antibacterial mechanisms of TZ NC are proposed to involve membrane rupture, suppression of biofilm formation, and modulation of new cell wall and protein-synthesis-associated cellular pathways. Its biocompatibility against HCT116 cells was also checked. Our findings suggest that the TZ nanocomposite could improve the selectivity and bactericidal activity of THO against target species.
- Open Access
- 1 March 2022
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 12 (12) , 7268-7275
A MoS2 based silver-doped ZnO nanocomposite and its antibacterial activity against β-lactamase expressing Escherichia coli
Synthesis and activity of a MoS2 based nanoplatform.
- 1 March 2022
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 12 (12) , 7268-7275
Open AccessA MoS2 based silver-doped ZnO nanocomposite and its antibacterial activity against β-lactamase expressing Escherichia coli
Synthesis and activity of a MoS2 based nanoplatform.
- 1 June 2009
- Published by Wiley in SID Symposium Digest of Technical Papers
- Vol. 40 (1) , 20-24
4.3: Printed, Doped Flexible P‐OLED Displays and Lighting
Add‐Vision has brought a new perspective to OLED commercialization, devices, and manufacturing, based on doped organic semiconductor device chemistries and air stable cathode technology to enable low cost printing tools and flexible, lamination encapsulation. Add‐Vision's balance of cost, performance, and form factor are enabling advantages for new printed electronics opportunities outside of conventional high resolution display applications, and complex and high capital cost processing.
- 1 June 2009
- Published by Wiley in SID Symposium Digest of Technical Papers
- Vol. 40 (1) , 20-24
4.3: Printed, Doped Flexible P‐OLED Displays and Lighting
Add‐Vision has brought a new perspective to OLED commercialization, devices, and manufacturing, based on doped organic semiconductor device chemistries and air stable cathode technology to enable low cost printing tools and flexible, lamination encapsulation. Add‐Vision's balance of cost, performance, and form factor are enabling advantages for new printed electronics opportunities outside of conventional high resolution display applications, and complex and high capital cost processing.